EUA Requirements - Mpje

1. What is the pharmacist's obligation if state law conflicts with an EUA-required condition of use?

   Follow the EUA condition; it can preempt conflicting state requirements. Federal preemption under EUA authority allows overriding conflicting state laws to facilitate uniform emergency response.

2. Which requirement is generally expected under EUA for tracking and reporting adverse events?

   Report specified adverse events to FDA/VAERS/MedWatch per LOA. EUAs typically mandate reporting serious adverse events to systems like VAERS or MedWatch to monitor safety during emergency use.

3. Identify the correct action if a prescriber requests an EUA product for a non-authorized indication.

   Do not dispense under the EUA; dispense only within EUA scope. Dispensing outside EUA scope violates federal authorization, as EUAs limit use to specified indications for emergency needs.

4. Which document must a pharmacist follow to apply EUA dispensing and documentation requirements for a specific product?

   The product-specific EUA Letter of Authorization (LOA). The LOA details product-specific requirements, including dispensing, administration, and documentation, which must be adhered to for compliance.

5. What is the legal status of EUA conditions for use when dispensing an EUA product?

   They are mandatory conditions of authorization. EUA conditions, outlined in the LOA, are legally binding to ensure safe and effective use during the emergency.

6. What is the correct action if an EUA product is expired but still in inventory?

   Quarantine and do not dispense; follow EUA/LOA disposition instructions. Expired products under EUA must be isolated to prevent use, with disposition following LOA to ensure safety.

7. Which labeling rule applies if an EUA product has EUA-specific labeling different from FDA-approved labeling?

   Use EUA-authorized labeling and instructions, not standard approved labeling. EUA-specific labeling provides emergency-tailored information, superseding standard labeling to address the specific crisis.

8. Which requirement applies if an EUA product is authorized only for specific age groups or weights?

   Confirm the patient meets the EUA age/weight limits before dispensing. Age and weight criteria in EUAs are based on available data to ensure safety and efficacy in targeted groups.

9. Which option best describes pharmacist authority when an EUA expressly authorizes pharmacists to prescribe or order?

   Pharmacists may prescribe/order only to the extent authorized by the EUA. Certain EUAs expand pharmacist scope to include prescribing for efficient distribution during emergencies.

10. Which action is required if an EUA product has specific storage or handling conditions in the LOA?

    Store and handle exactly per EUA-authorized labeling/LOA conditions. Adhering to specified storage and handling maintains product integrity and efficacy as authorized under the EUA.

11. What must a pharmacist verify when an EUA limits use to certain patients or indications?

    Patient eligibility matches the EUA-authorized criteria. Verification ensures the product is used only for authorized populations, aligning with EUA scope and safety data.

12. What is the correct action if an EUA requires reporting dispensing data to a government system?

    Submit required dispensing/administration data per EUA timelines. Reporting data to government systems aids in monitoring usage, inventory, and effectiveness during the emergency.

13. Identify the correct action if the EUA requires documenting recipient counseling or Fact Sheet provision.

    Document that the Fact Sheet was provided per EUA requirements. Documentation confirms compliance with EUA mandates for informing recipients, supporting accountability and legal requirements.

14. Which requirement commonly appears in EUAs regarding distribution channels for the product?

    Dispense only through authorized distribution and eligible sites per LOA. EUAs often restrict distribution to ensure controlled access and prevent misuse during public health emergencies.

15. What EUA-required information must be provided to recipients when an EUA product is dispensed or administered?

    The EUA Fact Sheet (for patients/recipients or caregivers). Federal law mandates providing recipients with EUA Fact Sheets to inform them about the product, risks, benefits, and right to refuse.

16. Which statement best describes patient consent for an EUA product under federal law?

    Recipients must be informed it is EUA-authorized and may accept or refuse. EUA statute requires informing recipients of the unapproved status and their option to accept or refuse, promoting informed consent.

17. Which option best describes how to handle EUA product substitution (brand/generic) at the pharmacy?

    Substitute only if the EUA/LOA and state law permit that substitution. Substitution must comply with EUA terms and state pharmacy laws to maintain equivalence and authorization integrity.

18. Which EUA-required information must be available to the dispensing or administering clinician?

    The EUA Fact Sheet for Healthcare Providers. Healthcare providers must have access to detailed EUA information on dosing, contraindications, and monitoring to ensure proper use.

19. What is the correct action if an EUA is terminated or revoked for a product you dispense?

    Stop dispensing under the EUA and follow FDA/LOA transition guidance. Termination ends EUA authority, necessitating transition to approved alternatives or cessation to comply with federal law.

20. What is the correct documentation action when an EUA requires lot number capture for each dose or unit?

    Record the lot number as required by the EUA/LOA. Capturing lot numbers enables tracking for quality control, recalls, and adverse event investigations under EUA.

21. What is the correct action when an EUA is revised and the LOA/Facts Sheets are updated?

    Use the most current EUA LOA and current Fact Sheets immediately. Updates reflect new data or conditions, requiring immediate implementation to maintain authorization validity.

22. Which federal authority issues an EUA for drugs, biologics, or devices in the United States?

    FDA (Food and Drug Administration). Under FD&C Act, FDA has authority to declare and issue EUAs for medical products during qualifying emergencies.

23. Which requirement applies if an EUA product is authorized with specific patient screening (for example, labs or vitals)?

    Ensure required screening is completed/verified per EUA before use. Screening requirements in EUAs ensure patient suitability and minimize risks based on available emergency data.

24. What is the primary federal standard for recordkeeping when dispensing an EUA product?

    Maintain records as specified in the EUA LOA and applicable law. Recordkeeping ensures traceability and compliance, with specifics dictated by the LOA and relevant federal or state regulations.

Study these flashcards